By ROBERT CYRAN
The health care giant is criticized by many investors for its mediocre shareholder returns and its lack of merger-and-acquisition activity.
Published: June 3, 2016 at 12:00AM
from NYT Business Day http://ift.tt/1PowyRb
from WordPress http://ift.tt/1PoB8i7
via Hadi Aboukhater
No comments:
Post a Comment